Information  X 
Enter a valid email address

ONCIMMUNE (ONC)

Date Time Source Announcement
15 Feb 2021 7:00 am
RNS
Interim Results
25 Jan 2021 7:00 am
RNS
Notice of Half Year Results
19 Jan 2021 4:17 pm
RNS
Directorate Change
18 Jan 2021 11:37 am
RNS
Holding(s) in Company
14 Jan 2021 9:49 am
RNS
PDMR Dealing
06 Jan 2021 10:27 am
RNS
Total Voting Rights
18 Dec 2020 7:00 am
RNS
PDMR Dealing
15 Dec 2020 7:00 am
RNS
Autoantibody profiles publication for RA treatment
14 Dec 2020 7:00 am
RNS
EarlyCDT Lung blood test launch into the NHS
30 Nov 2020 11:21 am
RNS
Results of Annual General Meeting
11 Nov 2020 7:00 am
RNS
Agreement with Augmenta Bioworks
09 Nov 2020 7:00 am
RNS
Notice of AGM and Posting of Annual Report
30 Oct 2020 7:00 am
RNS
Full year results and progress update
28 Oct 2020 7:00 am
RNS
Clinical study initiated by Biodesix in US
21 Oct 2020 7:00 am
RNS
Abstracts of Studies using EarlyCDT Lung
19 Oct 2020 8:21 am
RNS
Replacement: Notice of Full Year Results
13 Oct 2020 7:00 am
RNS
Agreement with Cedars-Sinai to Profile COVID-19
08 Oct 2020 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
06 Oct 2020 7:00 am
RNS
UK Government funding for tool for use in COVID-19
23 Sep 2020 7:00 am
RNS
Profiling samples from Genentech
15 Sep 2020 2:00 pm
RNS
Block Admission
11 Sep 2020 12:14 pm
RNS
New Incentivisation Scheme for Senior Management
03 Sep 2020 7:00 am
RNS
Cost-effectiveness study assessing EarlyCDT Lung
02 Sep 2020 7:00 am
RNS
Autoantibody profiling agreement signed
13 Aug 2020 11:38 am
RNS
Exercise of Options and Total Voting Rights
12 Aug 2020 7:00 am
RNS
Appointment of Joint Brokers
10 Aug 2020 7:00 am
RNS
EarlyCDT Lung Blood Test Featured on ITV News
07 Aug 2020 7:00 am
RNS
Exercise of Options and Total Voting Rights
05 Aug 2020 7:00 am
RNS
Further evidence for the use of the EarlyCDT Lung
31 Jul 2020 7:00 am
RNS
ERJ publishes results from the ECLS study
27 Jul 2020 7:00 am
RNS
Roche Contract Expansion to Profile Autoantibodies
24 Jul 2020 2:52 pm
RNS
Exercise of Options and Total Voting Rights
08 Jul 2020 7:00 am
RNS
Paper highlights potential of ImmunoINSIGHTS in RA
01 Jul 2020 7:00 am
RNS
Authorisation for EarlyCDT Lung in Brazil
30 Jun 2020 7:00 am
RNS
Exercise of Options
09 Jun 2020 3:54 pm
RNS
Grant of Options and PDMR notification
08 Jun 2020 7:00 am
RNS
Holdings in Company
05 Jun 2020 2:00 pm
RNS
Price Monitoring Extension
  9:02 am
RNS
CORRECTION: Director/PDMR's Dealing
  7:00 am
RNS
Director/PDMR's Dealing
04 Jun 2020 7:00 am
RNS
Trading Update for 12 months to 31 May 2020
02 Jun 2020 4:09 pm
RNS
Holding(s) in Company
29 May 2020 2:40 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Notice of Trading Update
28 May 2020 11:06 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Contract with Roche to Profile Autoantibodies
21 May 2020 7:00 am
RNS
EarlyCDT Lung Partnership Contract Signed
14 May 2020 7:00 am
RNS
Featured Presentation at ASCO 2020 Virtual Meeting
12 May 2020 7:00 am
RNS
Drug Development Collaboration Agreement Signed
06 May 2020 8:56 am
RNS
PDMR Dealing
04 May 2020 5:08 pm
RNS
Directorate Change
01 May 2020 10:32 am
RNS
Grant of Options and PDMR notification
24 Apr 2020 3:59 pm
RNS
Director/PDMR Shareholding
07 Apr 2020 11:41 am
RNS
PDMR Dealing
01 Apr 2020 10:31 am
RNS
PDMR Dealing
25 Mar 2020 12:42 pm
RNS
PDMR Dealing
20 Mar 2020 2:09 pm
RNS
Holding(s) in Company
18 Mar 2020 5:42 pm
RNS
Holding(s) in Company
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t